Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2012
Overview of alternative oligonucleotide chemistries for exon skippingAmer F Saleh, Andrey A Arzumanov, Michael J GaitToxicological Sciences : an Official Journal of the Society of Toxicology|February 26, 2015
Re-evaluation of the Mutagenic Response to Phosphorothioate Nucleotides in Human Lymphoblastoid TK6 CellsAmer F Saleh, Catherine C Priestley, Nigel J Gooderham, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|January 12, 2010
Improved Tat-mediated plasmid DNA transfer by fusion to LK15 peptideAmer F Saleh, Harmesh Aojula, Yamini Arthanari, et al.Bioconjugate Chemistry|October 1, 2010
Synthesis and splice-redirecting activity of branched, arginine-rich peptide dendrimer conjugates of peptide nucleic acid oligonucleotidesAmer F Saleh, Andrey Arzumanov, Rachida Abes, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|September 24, 2016
The Lack of Mutagenic Potential of a Guanine-Rich Triplex Forming Oligonucleotide in Physiological ConditionsAmer F Saleh, Mick D Fellows, Liming Ying, et al.Nucleic Acids Research|December 4, 2014
Bi-specific splice-switching PMO oligonucleotides conjugated via a single peptide active in a mouse model of Duchenne muscular dystrophyFazel Shabanpoor, Graham McClorey, Amer F Saleh, et al.Methods in Molecular Biology (Clifton, N.J.)|November 6, 2010
Splice redirection as a convenient assay to monitor CPP-ON efficiency and mechanismRachida Abes, Andrey A Arzumanov, Amer F Saleh, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 12, 2015
Combination Antisense Treatment for Destructive Exon Skipping of Myostatin and Open Reading Frame Rescue of Dystrophin in Neonatal mdx MiceNgoc B Lu-Nguyen, Susan A Jarmin, Amer F Saleh, et al.Molecular Therapy. Nucleic Acids|December 20, 2012
Dual Myostatin and Dystrophin Exon Skipping by Morpholino Nucleic Acid Oligomers Conjugated to a Cell-penetrating Peptide Is a Promising Therapeutic Strategy for the Treatment of Duchenne Muscular DystrophyAlberto Malerba, Jagjeet K Kang, Graham McClorey, et al.Molecular Therapy. Nucleic Acids|January 25, 2013
Pip6-PMO, A New Generation of Peptide-oligonucleotide Conjugates With Improved Cardiac Exon Skipping Activity for DMD TreatmentCorinne Betts, Amer F Saleh, Andrey A Arzumanov, et al.Pageof 3